Results Of The Randomised Phase II NCRI Arctic (Attenuated dose Rituximab with ChemoTherapy In CLL) Trial Of Low Dose Rituximab In Previously Untreated CLL
暂无分享,去创建一个
W. Gregory | A. Schuh | A. Duncombe | D. Milligan | A. Rawstron | D. Allsup | S. Marshall | A. Varghese | P. Hillmen | L. McParland | C. Collett | T. Munir | A. Chalmers | Alex Smith | Dena Cohen